BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2582468)

  • 1. [Intensive post-remission therapy of acute myeloid leukemia with high doses of cytosine arabinoside].
    Slechtová J; Koza V; Svojgrová M; Cepelák V
    Cas Lek Cesk; 1989 Sep; 128(39):1239-42. PubMed ID: 2582468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
    Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High doses of cytosine arabinoside in the treatment of patients with acute relapsing or refractory leukemia].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ; Marín-López A
    Rev Invest Clin; 1989; 41(2):139-45. PubMed ID: 2675236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensification in post-remission treatment of adult acute non lymphocytic leukemia.
    Petti MC; Aloe Spiriti MA; Carella AM; Fioritoni G; Resegotti L; Rizzoli V; Tabilio A; Visani G; Vegna ML; Mandelli F
    Haematologica; 1989; 74(3):267-71. PubMed ID: 2511095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside].
    Pedersen G; Stentoft J; Pedersen JO; Jensen MK
    Ugeskr Laeger; 1994 Oct; 156(43):6380-4. PubMed ID: 7810014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
    Rossi Ferrini P; Ciolli S; Leoni F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():36-7. PubMed ID: 2713558
    [No Abstract]   [Full Text] [Related]  

  • 7. One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.
    Jourdan E; Rigal-Huguet F; Marit G; Vey N; Dastugue N; Fegueux N; Molina L; Gastaut JA; Legros L; Zerazhi H; Cailleres S; Bauduer F; Bordessoule D; Attal M; Blaise D; Pigneux A;
    Br J Haematol; 2005 May; 129(3):403-10. PubMed ID: 15842665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].
    Marit G; David B; Reiffers J; Broustet A
    Bull Cancer; 1985; 72(1):37-41. PubMed ID: 3857082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
    Osman I; Akin U; Ismet A; Meral B; Hamdi A; Haluk K
    Haematologia (Budap); 1996; 27(2):93-7. PubMed ID: 14651226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
    Insiripong S; Thaisamakr S
    J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
    Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
    Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Savani B
    Neoplasma; 1999; 46(1):61-5. PubMed ID: 10355536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
    Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
    Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.
    Invernizzi R; Pecci A; Rossi G; Pelizzari AM; Giusto M; Tinelli C; Ascari E
    Haematologica; 1997; 82(6):660-3. PubMed ID: 9499664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor for the treatment of relapsed acute myeloid leukemia].
    Saito K
    Rinsho Ketsueki; 1996 Aug; 37(8):651-3. PubMed ID: 8827872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia].
    Saito K; Furusawa S; Yamada K; Waga K; Aoyagi A; Koike T; Arimura H; Noguchi M; Yamato H; Sakuma H
    Rinsho Ketsueki; 1995 Mar; 36(3):165-74. PubMed ID: 7540220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of the treatment of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
    Brodzki LM; Pawelski S; Gepner-Woźniewska M
    Pol Tyg Lek; 1988 Mar; 43(11):355-8. PubMed ID: 3045770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.